These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Current status of HIV vaccine development]. Seki S; Matano T Nihon Rinsho; 2008 Oct; 66(10):1965-9. PubMed ID: 18939498 [TBL] [Abstract][Full Text] [Related]
47. Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine. Belyakov IM; Ahlers JD Trends Immunol; 2008 Nov; 29(11):574-85. PubMed ID: 18838298 [TBL] [Abstract][Full Text] [Related]
48. CTL ontogeny and viral escape: implications for HIV-1 vaccine design. Yang OO Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041 [No Abstract] [Full Text] [Related]
49. HIV and SIV CTL escape: implications for vaccine design. Goulder PJ; Watkins DI Nat Rev Immunol; 2004 Aug; 4(8):630-40. PubMed ID: 15286729 [No Abstract] [Full Text] [Related]
50. Development of prophylactic AIDS vaccines: the current state of affairs. Hanke T Curr Opin Mol Ther; 2003 Feb; 5(1):25-32. PubMed ID: 12669467 [TBL] [Abstract][Full Text] [Related]
51. Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection. Price DA; O'callaghan CA; Whelan JA; Easterbrook PJ; Phillips RE Clin Sci (Lond); 1999 Dec; 97(6):707-18. PubMed ID: 10585898 [TBL] [Abstract][Full Text] [Related]
53. Correlates of cytotoxic T-lymphocyte-mediated virus control: implications for immunosuppressive infections and their treatment. Wodarz D; Nowak MA Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1059-70. PubMed ID: 11186307 [TBL] [Abstract][Full Text] [Related]
54. No vaccine against HIV yet--are we not perfectly equipped? Singh M Virol J; 2006 Aug; 3():60. PubMed ID: 16939652 [TBL] [Abstract][Full Text] [Related]